BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, August 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 14, 2020
View Archived Issues
Base editor targets mitochondrial DNA
Read More
KPG-121, a cereblon modulator, shows promising antitumor activity in vitro and in vivo
Read More
Recombinant Bifidobacterium longum APS-002 secretes T-cell-redirecting diabody DBERB1
Read More
Metagenomic data aid phage therapy development
Read More
Discovery of KB-00130742 as orally bioavailable and ultra-selective inhibitor of CDK9
Read More
CCX-6569 shows promising antitumor activity in model of colon adenocarcinoma
Read More
Huihan Medical Technologies discloses new Wnt signaling inhibitors
Read More
Merck & Co. describes new anti-HIV compounds
Read More
New bacterial DNA gyrase/DNA topoisomerase IV inhibitors discovered at Roche
Read More
PharmaBlock Sciences identifies influenza virus replication inhibitors
Read More
Novel SSTR antagonist [177Lu]DOTA-LM3 shows promising results in patients with NENs
Read More
Novartis patents mutant CFTR correctors
Read More
Positive preclinical data for AdCOVID intranasal COVID-19 vaccine candidate
Read More
New sulfonamide derivatives as potent, selective and state-dependent Nav1.7 inhibitors for pain
Read More
BAN-2401 to be evaluated in new phase III AHEAD 3-45 program
Read More
Shanghai Junshi and Revitope enter into research collaboration and license agreement
Read More
Results of a phase III trial of reltecimod in severe necrotizing soft tissue infections
Read More
Dewpoint and Merck & Co. collaborate to develop condensate-based drug candidates against HIV
Read More
Interim phase I data presented for CTT-1403 in mCRPC
Read More
MHRA grants early access to lumasiran in the U.K.
Read More
INmune Bio reports interim phase Ib data on XPro-1595 in Alzheimer's disease
Read More
First patient dosed in OLE/switch study of FT-218 in narcolepsy
Read More
Immunomedics and Roche expand collaboration to study Trodelvy with Tecentriq
Read More
Innovation Pharmaceuticals provides updates regarding clinical testing of brilacidin in COVID-19
Read More
Arcutis begins phase IIb portion of phase I/IIb study of ARQ-252 for chronic hand eczema
Read More
